Tc-99m-methoxy isobutyl isonitrile scintimammography: imaging postexcision biopsy for residual and multifocal breast tumor

Nuclear Medicine Communications

Volumn 29, Issue 9, 2008, Pages 826-829

  Usmani, Sharjeel ^a,b   Khan, Haider Ali ^a,b   Niaz, Khalid ^a,b   Uz Zaman, Maseeh ^a,b   Niyaz, Kashif ^a,b   Javed, Amir ^a,b   al Mohannadi, Shihab ^a,b   al Huda, Fawaz Abu ^a,b   Kamal, Shahid ^a,b  

^a Karachi Institute of Radiotherapy & Nuclear Medicine   (Pakistan)

^b Hussain Makki Al Jumma Centre for Specialized Surgery HMJCSS   (Kuwait)

Author keywords

Breast carcinoma; Excision biopsy; Lumpectomy; Scintimammography

Indexed keywords

DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BIOPSY; BREAST TUMOR; DIAGNOSTIC IMAGING; FEMALE; HUMAN; INSTRUMENTATION; MAMMOGRAPHY; METHODOLOGY; MIDDLE AGED; ONCOLOGY; PATHOLOGY; PREDICTION AND FORECASTING; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; ACCURACY; BREAST BIOPSY; CLINICAL ARTICLE; HISTOPATHOLOGY; HUMAN TISSUE; MINIMAL RESIDUAL DISEASE; MULTIPLE CANCER; NEGATIVE PREDICTIVE VALUE; PARAMETER; PARTIAL MASTECTOMY; POSITIVE PREDICTIVE VALUE; POSTOPERATIVE PERIOD; SCINTILLATION CAMERA; SCINTIMAMMOGRAPHY;

ADULT; AGED; BIOPSY; BREAST NEOPLASMS; DIAGNOSTIC IMAGING; FEMALE; HUMANS; MAMMOGRAPHY; MEDICAL ONCOLOGY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 53149137107     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328302cce6     Document Type: Article

References (27)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ, et al. Cancer statistics, 2003. CA Cancer J Clin 2003; 53:5-26.
2. American Cancer Society. Breast cancer facts & figures. Atlanta, GA: American Cancer Society; 2003.
3. Rhodes DJ, Connor MK, Phillips SW, Smith RL, Collin DA. Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast. Mayo Clin Proc 2005; 80:24-30.
4. 99mTc-sestamibi breast imaging: multicentre trial results. J Nucl Med 2000; 41:1973-1979.
5. Khalkhali I, Cutrone JA, Mena IG, Diggles LE, Venegas RJ, Vargas HI, et al. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 1995; 196:421-426.
6. Romero L, Khalkhali I, Varqas HI. The role of nuclear medicine in breast cancer detection: a focus on technetium-99 sestamibi. Curr Oncol Rep 2003; 5:58-62.
7. Vecchio SD, Ciarmiello A, Pace L, Potena MI, Carriero MV, Thomas R, et al. Fractional retention of Tc-99m-Sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients. J Nucl Med 1997; 38:1348-1351.
8. Kolasinska AD, Buscombe JR, Cwikla JB, Holloway B, Parbhoo SP, Davidson T, et al. The role of scintimammography and mammography in recurrent breast cancer: evaluation of their accuracy using ROC curves. Nucl Med Rev Cent East Eur 2001; 4:77-82.
9. Cwikla JB, Kolasinska A, Buscombe JR, Hilson AJ. Tc-99m MIBI in suspected recurrent breast cancer. Cancer Biother Radiopharm 2000; 15:367-372.
10. 99mTc-MIBI in the assessment of patients with suspected recurrent breast cancer. Nucl Med Comm 1998; 19:649-655.
11. Choudhury PS, Kumar R, Pandey KK. Feasibility of scintimammography in restaging of breast carcinoma post lumpectomy for planning further management: a pilot study. World J Nucl Med 2003; 2:211-215.
12. Jardines L, Fowble B, Schultz D, Mackie J, Buzby G, Torosian M, et al. Factors associated with a positive reexcision after excisional biopsy for invasive breast cancer. Surgery 1995; 118:803-809.
13. Gwin JL, Eisenberg BL, Hoffman JP, Oftery FD, Boraas M, Solin LL. Incidence of gross and microscopic carcinoma in specimens from patients with breast cancer after re-excision lumpectomy. Ann Surg 1993; 218:729-734.
14. Herman K, Rodger JW. Ongoing care of patients after primary treatment for their cancer. CA Cancer J Clin 2003; 53:172-196.
15. Krishnamurthy R, Whitman GJ, Stelling CB, Anne C. Mammographic findings after breast conservation therapy. Radiographics 1999; 19:S53-S56.
16. Fisher B, Anderson S, Bryant J. Twenty year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Eng J Med 2002; 347:1233-1241.
17. Gluck BS, Dershaw DD, Liberman L, Deutch BM. Microcalcifications on postoperative mammograms as an indicator of adequacy of tumor excision. Radiology 1993; 188:469-472.
18. Beron PJ, Horwitz EM, Martinez AA, Wimbish KJ, Levine AJ, Gustafson G, et al. Pathologic and mammographic findings predicting the adequacy of tumor excision before breast conserving therapy. AJR 1996; 167:1409-1414.
19. Soderstrom CE, Harms SE, Farrell RS Jr, Pruneda JM, Flamig DP. Detection with MR imaging of residual tumor in the breast soon after surgery. AJR 1997; 168:485-488.
20. Frei KA, Kinkel K, Bonel HM, Ying Lu, Esserman LJ, Hylton NM. MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging. AJR 2000; 175:1577-1584.
21. Temple LKF, Wang EEL. Preventive health care update: follow up of breast cancer. CMAJ 1999; 16:1001-1008.
22. Jager JJ, Langendijk JA, Dohmen JP, Schreutelkemp IL, Volovics L, van Engelshoven JM, et al. Mammography in the follow up after breast conserving treatment in cancer of the breast: susceptibility for mammographic interpretation, validity and interobserver variation. Br J Radiol 1995; 68:754-760.
23. Mendelson EB. Evaluation of the postoperative breast. Radiol Clin North Am 1992; 30:107-138.
24. Orel SG, Reynolds C, Schnall MD, Solin LJ, Fraker DL, Sullivan DC. Breast carcinoma: MR imaging before re-excisional biopsy. Radiology 1997; 205:429-436.
25. Khalkhal I, Itti E. Functional breast imaging using the single photon technique. Nucl Med Commun 2002; 23:609-611.
26. Ciarmiello A, Del Vecchio S, Silvestro P, Potena MI, Carriero MV, Thomas R, et al. Tumour clearance of Technetium-99m-sestamibi as a predictor of the response to neoadjuvant chemotherapy for locally advanced breast carcinoma. J Clin Oncol 1998; 16:1677-1683.
27. Bombardieri E, Aktolun C, Baum RP, Delaloye AB, Buscombe JR, Chatal JF, et al. Breast scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging 2003; 30:BP107-BP114.